Arrowstreet Capital, Limited Partnership Haemonetics Corp Transaction History
Arrowstreet Capital, Limited Partnership
- $114 Billion
- Q2 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Haemonetics Corp stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 110,110 shares of HAE stock, worth $10.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
110,110
Previous 167,497
34.26%
Holding current value
$10.3 Million
Previous $14.3 Million
36.28%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding HAE
# of Institutions
337Shares Held
55.5MCall Options Held
465KPut Options Held
128K-
Capital Research Global Investors Los Angeles, CA6.92MShares$646 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$556 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$480 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$358 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$358 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.79B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...